Everolimus for advanced breast cancer: Is the histological subtype important?

被引：0
|
作者：
Vargas, Alicia
Flores Paco, Pablo
De La Haba, Juan
Morales-Estevez, Cristina
Rodriguez-Alonso, Beatriz
Porras, Ignacio
de la Cruz-Merino, Luis
Munoz, Clara
Lorente, Margarita
Gonzalez Flores, Encarnacion
Sanchez-Rovira, Pedro
Arenas, Rafael
Armenta, Ana
Aranda, Enrique
机构：
[1] Univ Reina Sofia Hosp, Cordoba, Spain
[2] Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain
[3] Univ Cordoba, Univ Reina Sofia Hosp, Cordoba, Spain
[4] GEICAM Spanish Breast Canc Grp, Cordoba, Spain
[5] Hosp Univ Virgen Macarena, Seville, Spain
[6] Virgen Macarena Univ Hosp, Seville, Spain
[7] Virgen de las Nieves Univ Hosp, Granada, Spain
[8] Virgen de las Nieves Hosp, Granada, Spain
[9] Hosp Univ Jaen, Jaen, Spain
[10] GEICAM Spanish Breast Canc Grp, Jaen, Spain
[11] Univ Reina Sofia Hosp, Dept Med Oncol, Cordoba, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13165
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Everolimus combination prolongs PFS in HER2-positive advanced breast cancer
    Fuerst, Mark L.
    FORMULARY, 2013, 48 (07) : 238 - 238
  • [32] Everolimus pharmacokinetics and exposure-response relationship in Japanese patients with advanced breast cancer
    Hirabatake, Masaki
    Mizuno, Tomoyuki
    Kato, Hironori
    Hashida, Tohru
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [33] One step forward, two steps back: The story of everolimus in advanced breast cancer
    Niraula, Saroj
    Ocana, Alberto
    Amir, Eitan
    BREAST, 2015, 24 (05): : 529 - 531
  • [34] Cost-effectiveness and safety of palbociclib and everolimus for treating advanced and recurrent breast cancer
    Kimura, M.
    Usami, E.
    Yoshimura, T.
    PHARMAZIE, 2019, 74 (12): : 763 - 766
  • [35] Actionable Genetic Alterations in Advanced Breast Cancer: A Frequency Analysis by Molecular Subtype
    Abbott, Sara E.
    Broaddus, Russell
    Chen, Hui
    MODERN PATHOLOGY, 2018, 31 : 42 - 42
  • [36] Actionable Genetic Alterations in Advanced Breast Cancer: A Frequency Analysis by Molecular Subtype
    Abbott, Sara E.
    Broaddus, Russell
    Chen, Hui
    LABORATORY INVESTIGATION, 2018, 98 : 42 - 42
  • [37] Role of MRI in the staging of breast cancer patients: does histological type and molecular subtype matter?
    Bitencourt, Almir G. V.
    Pereira, Nara P.
    Franca, Luciana K. L.
    Silva, Caroline B.
    Paludo, Jociana
    Paiva, Hugo L. S.
    Graziano, Luciana
    Guatelli, Camila S.
    Souza, Juliana A.
    Marques, Elvira F.
    BRITISH JOURNAL OF RADIOLOGY, 2015, 88 (1055):
  • [38] Associations of radiotherapy receipt with lung cancer risk by histological subtype among breast cancer survivors in the United States
    Jiang, Chenxi
    Freedman, Rachel A.
    Punglia, Rinaa S.
    Jemal, Ahmedin
    Sung, Hyuna
    INTERNATIONAL JOURNAL OF CANCER, 2025, 156 (06) : 1114 - 1120
  • [39] Everolimus and exemestane in hormone receptor positive advanced breast cancer: A comprehensive cancer center's experience
    Moreira, Ines
    Afonso, Ana
    Abreu, Miguel
    Sousa, Susana
    Ferreira, Marta
    BULLETIN DU CANCER, 2022, 109 (06) : 723 - 725
  • [40] The importance of treating by histological subtype in advanced soft tissue sarcoma
    Martin Broto, Javier
    Le Cesne, Axel
    Reichardt, Peter
    FUTURE ONCOLOGY, 2017, 13 (01) : 23 - 31
12345